Thiol-based SAHA analogues as potent histone deacetylase inhibitors

Thiol-based SAHA analogues as potent histone deacetylase inhibitors Novel Inhibitors of Human Histone Deacetylases:  Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C6 position Design, synthesis and biological evaluation of saccharin-based N -hydroxybenzamides as histone deacetylases (HDACs) inhibitors Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design